Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 2/2017

01-02-2017 | CORR Insights

CORR Insights®: Are Biopsy Tracts a Concern for Seeding and Local Recurrence in Sarcomas?

Author: Michelle Ghert, MD, FRCSC

Published in: Clinical Orthopaedics and Related Research® | Issue 2/2017

Login to get access

Excerpt

For patients with a bone or soft-tissue sarcoma, the critical step in directing treatment and determining prognosis is a tissue biopsy. Biopsies are commonly done by core needle biopsy with radiological assistance (ultrasound or CT scan), or by open surgical biopsy. Both methods generally provide sufficient material to determine a diagnosis, although open biopsy is more likely to do so at the cost of greater morbidity [1, 12]. Once a diagnosis is obtained and the definitive surgical resection is planned, the surgeon must decide whether or not to resect the biopsy tract along with the tumor. Due to the larger exposure and higher volume of exposed tumor tissue in surgical biopsies compared to needle biopsies, the risk for biopsy tract seeding with tumor cells is higher for open biopsies than for core needle biopsies. Fortunately, open-biopsy tracts are generally easy to see and resect; for this reason, and because of the increased risk of seeding associated with them, surgeons accept that open biopsy tracts should be excised at the time of the definitive tumor resection. …
Literature
1.
go back to reference Altuntas AO, Slavin J, Smith PJ, Schlict SM, Powell GJ, Ngan S, Toner G, Choong PFM. Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours. ANZ J Surg. 2005;75:187–191.CrossRefPubMed Altuntas AO, Slavin J, Smith PJ, Schlict SM, Powell GJ, Ngan S, Toner G, Choong PFM. Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours. ANZ J Surg. 2005;75:187–191.CrossRefPubMed
2.
go back to reference Becker M, Graf C, Tonak M, Radsak MP, Bopp T, Bals R, Bohle RM, Theobald M, Rommens P-M, Proschek D, Wehler TC. Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. Oncol Lett. 2016;12:1257–1264.PubMedPubMedCentral Becker M, Graf C, Tonak M, Radsak MP, Bopp T, Bals R, Bohle RM, Theobald M, Rommens P-M, Proschek D, Wehler TC. Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. Oncol Lett. 2016;12:1257–1264.PubMedPubMedCentral
3.
go back to reference Binitie O, Tejiram S, Conway S, Cheong D, Temple HT, Letson GD. Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract. Clin Orthop Relat Res. 2013;471:891–898.CrossRefPubMed Binitie O, Tejiram S, Conway S, Cheong D, Temple HT, Letson GD. Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract. Clin Orthop Relat Res. 2013;471:891–898.CrossRefPubMed
4.
go back to reference Chui MH, Kandel RA, Wong M, Griffin AM, Bell RS, Blackstein ME, Wunder JS, Dickson BC. Histopathologic features of prognostic significance in high-grade osteosarcoma. Arch Pathol Lab Med. [Published online ahead of print August 23, 2016]. DOI: 10.5858/arpa.2015-0389-OA. Chui MH, Kandel RA, Wong M, Griffin AM, Bell RS, Blackstein ME, Wunder JS, Dickson BC. Histopathologic features of prognostic significance in high-grade osteosarcoma. Arch Pathol Lab Med. [Published online ahead of print August 23, 2016]. DOI: 10.​5858/​arpa.​2015-0389-OA.
5.
go back to reference Hemmati M, Abbaspour A, Alizadeh AM, Khaniki M, Amanzadeh A, Mohagheghi MA, Mousavi MS. Rat xenograft chondrosarcoma development by human tissue fragment. Exp. Oncol. 2011;33:52–54.PubMed Hemmati M, Abbaspour A, Alizadeh AM, Khaniki M, Amanzadeh A, Mohagheghi MA, Mousavi MS. Rat xenograft chondrosarcoma development by human tissue fragment. Exp. Oncol. 2011;33:52–54.PubMed
6.
go back to reference Kawano S, Grassian AR, Tsuda M, Knutson SK, Warholic NM, Kuznetsov G, Xu S, Xiao Y, Pollock RM, Smith JS, Kuntz KK, Ribich S, Minoshima Y, Matsui J, Copeland RA, Tanaka S, Keilhack H. Preclinical evidence of anti-tumor activity induced by EZH2 inhibition in human models of synovial sarcoma. PloS One. 2016;11:e0158888.CrossRefPubMedPubMedCentral Kawano S, Grassian AR, Tsuda M, Knutson SK, Warholic NM, Kuznetsov G, Xu S, Xiao Y, Pollock RM, Smith JS, Kuntz KK, Ribich S, Minoshima Y, Matsui J, Copeland RA, Tanaka S, Keilhack H. Preclinical evidence of anti-tumor activity induced by EZH2 inhibition in human models of synovial sarcoma. PloS One. 2016;11:e0158888.CrossRefPubMedPubMedCentral
7.
go back to reference Kenan S, Steiner GC. Experimental transplantation of the Swarm rat chondrosarcoma into bone: Radiological and pathological studies. J Orthop. 1991;9:445–451. Kenan S, Steiner GC. Experimental transplantation of the Swarm rat chondrosarcoma into bone: Radiological and pathological studies. J Orthop. 1991;9:445–451.
8.
go back to reference Kubicek GJ, LaCouture T, Kaden M, Kim TW, Lerman N, Khrizman P, Patel A, Xu Q, Lackman R. Preoperative radiosurgery for soft tissue sarcoma. Am J Clin Oncol. [Published online ahead of print November 3, 2015]. DOI: 10.1097/COC.0000000000000236. Kubicek GJ, LaCouture T, Kaden M, Kim TW, Lerman N, Khrizman P, Patel A, Xu Q, Lackman R. Preoperative radiosurgery for soft tissue sarcoma. Am J Clin Oncol. [Published online ahead of print November 3, 2015]. DOI: 10.​1097/​COC.​0000000000000236​.
9.
go back to reference Mak IW, Evaniew N, Ghert M. Lost in translation: Animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6:114–118.PubMedPubMedCentral Mak IW, Evaniew N, Ghert M. Lost in translation: Animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6:114–118.PubMedPubMedCentral
10.
go back to reference Maretty-Nielsen K, Aggerholm-Pedersen N, Safwat A, Jørgensen PH, Hansen BH, Baerentzen S, Pedersen AB, Keller J. Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: A cohort study of 922 consecutive patients. Acta Orthop. 2014;85:323–332.CrossRefPubMedPubMedCentral Maretty-Nielsen K, Aggerholm-Pedersen N, Safwat A, Jørgensen PH, Hansen BH, Baerentzen S, Pedersen AB, Keller J. Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: A cohort study of 922 consecutive patients. Acta Orthop. 2014;85:323–332.CrossRefPubMedPubMedCentral
11.
go back to reference Saghieh S, Masrouha KZ, Musallam KM, Mahfouz R, Abboud M, Khoury NJ, Haidar R. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010;30:80–83.PubMedPubMedCentral Saghieh S, Masrouha KZ, Musallam KM, Mahfouz R, Abboud M, Khoury NJ, Haidar R. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010;30:80–83.PubMedPubMedCentral
12.
go back to reference Traina F, Errani C, Toscano A, Pungetti C, Fabbri D, Mazzotti A, Donati D, Faldini C. Current concepts in the biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 2015;97:e7.CrossRef Traina F, Errani C, Toscano A, Pungetti C, Fabbri D, Mazzotti A, Donati D, Faldini C. Current concepts in the biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 2015;97:e7.CrossRef
Metadata
Title
CORR Insights®: Are Biopsy Tracts a Concern for Seeding and Local Recurrence in Sarcomas?
Author
Michelle Ghert, MD, FRCSC
Publication date
01-02-2017
Publisher
Springer US
Published in
Clinical Orthopaedics and Related Research® / Issue 2/2017
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-016-5117-4

Other articles of this Issue 2/2017

Clinical Orthopaedics and Related Research® 2/2017 Go to the issue